PDX Pharmaceuticals, Inc
- Biotech or pharma, therapeutic R&D
PDX Pharma's patented Pdx-NP™ nanoparticle platform effectively delivers therapeutics (siRNA, immunotherapy, tumor-homing antibody) to tumor tissues beyond the liver. The lead candidates not only kill cancer cells, but also stimulate antitumor immunity.